Bioanalytical Systems, Inc. Finalizes Sale of Baltimore Building.WEST LAFAYETTE West Lafayette, city (1990 pop. 25,907), Tippecanoe co., W Ind., a suburb of Lafayette, on the Wabash River; inc. 1924. A primarily residential city, it is the seat of Purdue Univ. , Ind. -- Bioanalytical Systems, Inc. (Nasdaq:BASI) announced today that it has closed on the previously announced sale of its downtown Baltimore Downtown Baltimore is the section of Baltimore traditionally bounded by Martin Luther King, Jr. Boulevard to the west, Mt. Royal Avenue to the north, President Street to the east and the Inner Harbor area to the south. , Maryland property to The Kevin F. Donahoe Company of Philadelphia, Pennsylvania. The sale price was $6.5 million, paid at the close. Concurrently, the Company completed a three-year leaseback A transaction whereby land is sold and subsequently rented by the seller from the purchaser who is the new owner. of a substantial portion of the building for use while it procures new space in the Baltimore area. Bioanalytical Systems, Inc. is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development and medical research companies. BASi focuses on developing innovative services and products that increase efficiency and reduce costs associated with taking new drugs to market. Visit www.bioanalytical.com for more about BASi. This release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the development of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks Operating risk The inherent or fundamental risk of a firm, without regard to financial risk. The risk that is created by operating leverage. Also called business risk. detailed in the company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion